相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of agonist efficacy in exposure-induced enhancement of mu opioid reward in rats
Megan J. Moerke et al.
NEUROPHARMACOLOGY (2019)
Determinants of opioid abuse potential: Insights using intracranial self-stimulation
S. Stevens Negus et al.
PEPTIDES (2019)
The analgesic efficacy of morphine varies with rat strain and experimental pain model: implications for target validation efforts in pain drug discovery
Sara Hestehave et al.
EUROPEAN JOURNAL OF PAIN (2019)
The role of transient receptor potential vanilloid receptor 1 and peroxisome proliferator-activated receptors-α in mediating the antinociceptive effects of palmitoylethanolamine in rats
Sara A. Aldossary et al.
NEUROREPORT (2019)
Effects of morphine/CP55940 mixtures on an impulsive choice task in rhesus monkeys
Vanessa Minervini et al.
BEHAVIOURAL PHARMACOLOGY (2018)
Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: Impact of drug and fixed-dose ratio
David R. Maguire et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Pharmacological characterization of intraplantar Complete Freund's Adjuvant-induced burrowing deficits
Stacey Anne Gould et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Role of PPARα and PPARγ in Mediating the Analgesic Properties of Ibuprofen in vivo and the Effects of Dual PPARα/γ Activation in Inflammatory Pain Model in the Rat
Mohammad Alsalem et al.
INTERNATIONAL JOURNAL OF PHARMACOLOGY (2016)
Effects of acute and repeated dosing of the synthetic cannabinoid CP55,940 on intracranial self-stimulation in mice
Travis W. Grim et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Dependence Potential of Tramadol: Behavioral Pharmacology in Rodents
Hye Jin Cha et al.
BIOMOLECULES & THERAPEUTICS (2014)
Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats
Michael D. Leitl et al.
MOLECULAR PAIN (2014)
Involvement of the opioid and cannabinoid systems in pain control: New insights from knockout studies
Xavier Nadal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ9-tetrahydrocannabinol in the rat
Rebecca M. Craft et al.
PAIN (2013)
Interactions between μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists in Rhesus Monkeys: Antinociception, Drug Discrimination, and Drug Self-Administration
David R. Maguire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Role of μ-opioid receptor reserve and μ-agonist efficacy as determinants of the effects of μ-agonists on intracranial self-stimulation in rats
Ahmad A. Altarifi et al.
BEHAVIOURAL PHARMACOLOGY (2012)
Interaction of Morphine and Selective Serotonin Receptor Inhibitors in Rats Experiencing Inflammatory Pain
Byung-Sang Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
Is There Any Clinically Relevant Cannabinoid-Induced Analgesia?
Birgit Kraft
PHARMACOLOGY (2012)
Dissociable Effects of the Cannabinoid Receptor Agonists Δ9-Tetrahydrocannabinol and CP55940 on Pain-Stimulated Versus Pain-Depressed Behavior in Rats
Andrew J. Kwilasz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Effects of Alterations in Cannabinoid Signaling, Alone and in Combination with Morphine, on Pain-Elicited and Pain-Suppressed Behavior in Mice
Laurence L. Miller et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence
Ahmad A. Altarifi et al.
BEHAVIOURAL PHARMACOLOGY (2011)
Cannabinoid-Opioid Interaction in Chronic Pain
D. I. Abrams et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Dissociation of rewarding, anti-aversive and anti-nociceptive effects of different classes of anti-nociceptives in the rat
Kris Rutten et al.
EUROPEAN JOURNAL OF PAIN (2011)
Anti-inflammatory and antihyperalgesic effects of the combination of ibuprofen and hemin in adjuvant-induced arthritis in the Wistar rat
Shamsherjit Kaur et al.
INFLAMMOPHARMACOLOGY (2011)
Cannabinoid-opioid interactions during neuropathic pain and analgesia
Ittai Bushlin et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity
Matthias Karst et al.
DRUGS (2010)
Evaluation of dosages and routes of administration of tramadol analgesia in rats using hot-plate and tail-flick tests
Coralie Zegre Cannon et al.
LAB ANIMAL (2010)
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
Praveen Anand et al.
BRAIN RESEARCH REVIEWS (2009)
The Endocannabinoid System and Pain
Josee Guindon et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain
Nova M. H. Sain et al.
NEUROPHARMACOLOGY (2009)
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Elizabeth J. Rahn et al.
NEUROTHERAPEUTICS (2009)
Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys:: discrimination and antinociception
Jun-Xu Li et al.
PSYCHOPHARMACOLOGY (2008)
Cannabinoids as potential new therapy for the treatment of gliomas
Daniela Parolaro et al.
Expert Review of Neurotherapeutics (2007)
Low dose combination of morphine and Δ9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent
Paul A. Smith et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration
John C. Ashton et al.
CURRENT NEUROPHARMACOLOGY (2007)
Increased tumor necrosis factor-α and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia:: The effects of analgesic drugs
Mauro Bianchi et al.
ANESTHESIA AND ANALGESIA (2007)
Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation
Kar-Chan Choong et al.
NEUROSCIENCE LETTERS (2007)
Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain
TL Burns et al.
ANNALS OF PHARMACOTHERAPY (2006)
Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine
JD Roberts et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat
S Vlachou et al.
PSYCHOPHARMACOLOGY (2005)
Synergistic and additive interactions of the cannabinoid agonist CP55,940 with μ opioid receptor and α2-adrenoceptor agonists in acute pain models in mice
SM Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Allodynia and hyperalgesia in adjuvant-induced arthritic rats: Time course of progression and efficacy of analgesics
Y Nagakura et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Antinociceptive synergy between Δ9-tetrahydrocannabinol and opioids after oral administration
DL Cichewicz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors
P Sacerdote et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
分享论文
